Related Experiment Videos
Identification of a human cDNA encoding a kinase-defective cdk5 isoform
M Moorthamer1, S Zumstein-Mecker, C Stephan
1Oncology Research, Novartis Pharma AG, Basel, Switzerland.
Biochemical and Biophysical Research Communications
|January 8, 1999
Summary
A novel cyclin-dependent kinase 5 (Cdk5) variant (Cdk5i) was discovered, lacking kinase activity. This Cdk5i isoform may regulate wild-type Cdk5 activity in human cells.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Cyclin-dependent kinase 5 (Cdk5) is crucial for neuronal and muscle cell differentiation.
- Cdk5 is activated by the brain-specific protein p35.
- The catalytic subunit of Cdk5 is widely expressed.
Purpose of the Study:
- To clone the cdk5 gene from a human fetal brain cDNA library.
- To characterize a newly identified variant of the cdk5 gene and its encoded protein.
- To investigate the functional implications of the Cdk5 variant in Cdk5 activity regulation.
Main Methods:
- Polymerase chain reaction (PCR) amplification from a human fetal brain cDNA library.
- Expression and purification of Cdk5 and its variant (Cdk5i) with p35 in insect cells.
- In vitro kinase assays to compare the activity of wild-type Cdk5/p35 and Cdk5i/p35 complexes.
Main Results:
- Two forms of the cdk5 gene were amplified: wild-type and a variant lacking the kinase domain VI (Cdk5i).
- The Cdk5i protein, when coexpressed with p35, formed a complex with reduced kinase activity compared to wild-type Cdk5/p35.
- Kinase-defective Cdk5i could inhibit the activity of wild-type Cdk5 when coexpressed with p35.
Conclusions:
- A novel Cdk5 isoform (Cdk5i) lacking kinase activity was identified.
- Cdk5i may function as a negative regulator of Cdk5 activity in human cells.
- The findings suggest a new regulatory mechanism for Cdk5 in cellular processes.